Palatin Technologies Inc (PTN): Free Cash Flow
-$13.58M
Year ended 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$13.58M | n/m | 2026-09-28, From 2025-07-01 |
| 2025-06-30 | -$21.31M | n/m | 2026-09-28, From 2024-07-01 |
| 2024-06-30 | -$31.50M | n/m | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | -$29.71M | n/c | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | -$30.18M | n/m | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | -$99.4K | n/m | 2022-09-22, From 2020-07-01 |
| 2020-06-30 | $41.26M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | -$21.82M | n/m | 2020-09-25, From 2018-07-01 |
| 2018-06-30 | $1.68M | -86.8% | 2020-09-25, From 2017-07-01 |
| 2017-06-30 | $12.75M | n/m | 2019-09-12, From 2016-07-01 |
| 2016-06-30 | -$47.38M | n/m | 2018-09-13, From 2015-07-01 |
| 2015-06-30 | -$13.36M | n/m | 2017-09-25, From 2014-07-01 |
| 2014-06-30 | -$12.21M | n/m | 2016-09-19, From 2013-07-01 |
| 2013-06-30 | -$13.71M | n/m | 2015-09-18, From 2012-07-01 |
| 2012-06-30 | -$15.49M | n/a | 2014-09-12, From 2011-07-01 |
| No annual figure between 2010-06-30 and 2012-06-30. | |||
| 2010-06-30 | -$5.74M | n/a | 2012-09-10, From 2009-07-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | -$13.58M | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | -$103.21M | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$76.68M | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$516.0K | n/m |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | -$63.51M | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$12.0K | n/m |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | -$39.64M | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$56.37M | n/m |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | -$72.45M | n/m |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗